Match tier
Listed
Presence
Current · Arkansas
Last published
2026
Sources
OpenAlex · ORCID
Refreshed
2026-10-05
M
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Michela Palmieri's research focuses on understanding disease mechanisms and exploring therapeutic strategies, with a significant emphasis on bone metabolism, cancer, and neurological disorders. Her work has investigated the role of specific molecular pathways and cellular components in disease progression and treatment resistance. For instance, she has studied the contribution of senescent osteocytes to bone destruction in breast cancer metastasis and explored the signaling axis in multiple myeloma that promotes chemoresistance.
In the realm of bone health, Palmieri has examined factors influencing bone loss and resorption. This includes investigating the impact of osteocyte expression of osteoprotegerin on bone resorption following denosumab discontinuation and the neutralization of oxidized phospholipids as a means to attenuate age-associated bone loss in mice. Her research also delves into neurological conditions, examining autophagic imbalances and potential therapeutic insights in Mecp2-deficient models, relevant to conditions like Rett syndrome.
Palmieri collaborates extensively with researchers at the University of Arkansas for Medical Sciences, including Elena Ambrogini, Teenamol E. Joseph, Charles A. O’Brien, and Horacio Gómez-Acevedo, with whom she has co-authored numerous publications. Her scholarly output is substantial, evidenced by 83 total publications and over 10,000 citations, contributing to her designation as a highly cited researcher.
Metrics
- h-index: 35
- Publications: 83
- Citations: 10,876
Positions
-
RTDA 2022–presentUniversità Vita-Salute San Raffaele Facoltà di Medicina e Chirurgia ORCID
-
Project Leader 2021–presentIRCCS Ospedale San Raffaele Division of Neuroscience ORCID
-
RTDAUniversity of Arkansas for Medical Sciences ORCID
-
IRCCS Ospedale San Raffaele 2019–2021Division of Neuroscience ORCID
-
Senior PostDoc 2016–2019IRCCS Ospedale San Raffaele Neuroscience ORCID
-
PostDoc 2011–2016Baylor College of Medicine Molecular and Human Genetics ORCID
-
PhD Student 2007–2010Telethon Institute of Genetics and Medicine Genetics ORCID
Selected Publications
-
Wnt10b is required for the increase in cancellous bone caused by oxidized phospholipids blockade (2026)
-
Deletion of the scavenger receptor Scarb1 in osteoblast progenitors and myeloid cells does not affect bone mass (2025)
-
Deletion of the scavenger receptor Scarb1 in osteoblast progenitors and myeloid cells does not affect bone mass (2025)
-
Plasma levels of anti phosphocholine IgM antibodies are negatively correlated with bone mineral density in humans (2025)
Collaboration Network
Top Collaborators
Alessandro D. Santin
University of Arkansas for Medical Sciences (US)
21 shared publications
- Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: Identification of candidate molecular markers for ovarian cancer diagnosis and therapy
- Human Papillomavirus Type 16 and 18 E7-Pulsed Dendritic Cell Vaccination of Stage IB or IIA Cervical Cancer Patients: a Phase I Escalating-Dose Trial
- Racial differences in the overexpression of epidermal growth factor type II receptor (HER2/neu): A major prognostic indicator in uterine serous papillary cancer
- Gene expression fingerprint of uterine serous papillary carcinoma: identification of novel molecular markers for uterine serous cancer diagnosis and therapy
- HPV16/18 E7-pulsed dendritic cell vaccination in cervical cancer patients with recurrent disease refractory to standard treatment modalities
Showing 5 of 21 shared publications
Stefania Bellone
University of Arkansas for Medical Sciences (US)
21 shared publications
- Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: Identification of candidate molecular markers for ovarian cancer diagnosis and therapy
- Human Papillomavirus Type 16 and 18 E7-Pulsed Dendritic Cell Vaccination of Stage IB or IIA Cervical Cancer Patients: a Phase I Escalating-Dose Trial
- Racial differences in the overexpression of epidermal growth factor type II receptor (HER2/neu): A major prognostic indicator in uterine serous papillary cancer
- Gene expression fingerprint of uterine serous papillary carcinoma: identification of novel molecular markers for uterine serous cancer diagnosis and therapy
- HPV16/18 E7-pulsed dendritic cell vaccination in cervical cancer patients with recurrent disease refractory to standard treatment modalities
Showing 5 of 21 shared publications
Sërgio Pecorelli
University of Brescia (IT)
19 shared publications
- Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: Identification of candidate molecular markers for ovarian cancer diagnosis and therapy
- Human Papillomavirus Type 16 and 18 E7-Pulsed Dendritic Cell Vaccination of Stage IB or IIA Cervical Cancer Patients: a Phase I Escalating-Dose Trial
- Racial differences in the overexpression of epidermal growth factor type II receptor (HER2/neu): A major prognostic indicator in uterine serous papillary cancer
- Gene expression fingerprint of uterine serous papillary carcinoma: identification of novel molecular markers for uterine serous cancer diagnosis and therapy
- HPV16/18 E7-pulsed dendritic cell vaccination in cervical cancer patients with recurrent disease refractory to standard treatment modalities
Showing 5 of 19 shared publications
Martin J. Cannon
University of Arkansas for Medical Sciences
17 shared publications
In database
- Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: Identification of candidate molecular markers for ovarian cancer diagnosis and therapy
- Human Papillomavirus Type 16 and 18 E7-Pulsed Dendritic Cell Vaccination of Stage IB or IIA Cervical Cancer Patients: a Phase I Escalating-Dose Trial
- Racial differences in the overexpression of epidermal growth factor type II receptor (HER2/neu): A major prognostic indicator in uterine serous papillary cancer
- Gene expression fingerprint of uterine serous papillary carcinoma: identification of novel molecular markers for uterine serous cancer diagnosis and therapy
- HPV16/18 E7-pulsed dendritic cell vaccination in cervical cancer patients with recurrent disease refractory to standard treatment modalities
Showing 5 of 17 shared publications
Elena Ambrogini
Central Arkansas Veterans Healthcare System
14 shared publications
In database
- Reduced osteoprotegerin expression by osteocytes may contribute to rebound resorption after denosumab discontinuation
- Neutralization of oxidized phospholipids attenuates age‐associated bone loss in mice
- A Neutralizing Antibody Targeting Oxidized Phospholipids Promotes Bone Anabolism in Chow-Fed Young Adult Mice
- A NOTCH3-CXCL12-driven myeloma-tumor niche signaling axis promotes chemoresistance in multiple myeloma
- Single-cell Transcriptome Analysis Identifies Senescent Osteocytes as Contributors to Bone Destruction in Breast Cancer Metastasis
Showing 5 of 14 shared publications
Stefania Canè
University of Arkansas for Medical Sciences (US)
12 shared publications
- Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: Identification of candidate molecular markers for ovarian cancer diagnosis and therapy
- Gene expression fingerprint of uterine serous papillary carcinoma: identification of novel molecular markers for uterine serous cancer diagnosis and therapy
- Human Kallikrein 6: A New Potential Serum Biomarker for Uterine Serous Papillary Cancer
- Discrimination between uterine serous papillary carcinomas and ovarian serous papillary tumours by gene expression profiling
- The novel serine protease tumor-associated differentially expressed gene-14 (KLK8/Neuropsin/Ovasin) is highly overexpressed in cervical cancer
Showing 5 of 12 shared publications
Charles A. O’Brien
Central Arkansas Veterans Healthcare System
11 shared publications
In database
- Local Production of Osteoprotegerin by Osteoblasts Suppresses Bone Resorption
- Reduced osteoprotegerin expression by osteocytes may contribute to rebound resorption after denosumab discontinuation
- Single-cell Transcriptome Analysis Identifies Senescent Osteocytes as Contributors to Bone Destruction in Breast Cancer Metastasis
- Deletion of the scavenger receptor Scarb1 in osteoblast progenitors does not affect bone mass
- RETRACTED: Deletion of the scavenger receptor Scarb1 in myeloid cells does not affect bone mass
Showing 5 of 11 shared publications
Alexander Burnett
University of Arkansas for Medical Sciences
9 shared publications
In database
- Racial differences in the overexpression of epidermal growth factor type II receptor (HER2/neu): A major prognostic indicator in uterine serous papillary cancer
- Gene expression fingerprint of uterine serous papillary carcinoma: identification of novel molecular markers for uterine serous cancer diagnosis and therapy
- HPV16/18 E7-pulsed dendritic cell vaccination in cervical cancer patients with recurrent disease refractory to standard treatment modalities
- Human Kallikrein 6: A New Potential Serum Biomarker for Uterine Serous Papillary Cancer
- Overexpression of kallikrein 10 (hK10) in uterine serous papillary carcinomas
Showing 5 of 9 shared publications
Juan J. Roman
University of Arkansas for Medical Sciences (US)
9 shared publications
- Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: Identification of candidate molecular markers for ovarian cancer diagnosis and therapy
- Human Papillomavirus Type 16 and 18 E7-Pulsed Dendritic Cell Vaccination of Stage IB or IIA Cervical Cancer Patients: a Phase I Escalating-Dose Trial
- HPV16/18 E7-pulsed dendritic cell vaccination in cervical cancer patients with recurrent disease refractory to standard treatment modalities
- Human Kallikrein 6: A New Potential Serum Biomarker for Uterine Serous Papillary Cancer
- The novel serine protease tumor-associated differentially expressed gene-14 (KLK8/Neuropsin/Ovasin) is highly overexpressed in cervical cancer
Showing 5 of 9 shared publications
Eliana Bignotti
University of Brescia (IT)
8 shared publications
- Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: Identification of candidate molecular markers for ovarian cancer diagnosis and therapy
- The novel serine protease tumor-associated differentially expressed gene-14 (KLK8/Neuropsin/Ovasin) is highly overexpressed in cervical cancer
- Induction of tumor-specific cytotoxicity in tumor infiltrating lymphocytes by HPV16 and HPV18 E7-pulsed autologous dendritic cells in patients with cancer of the uterine cervix
- In vitro induction of tumor-specific HLA class I-restricted CD8+ cytotoxic T lymphocytes from patients with locally advanced breast cancer by tumor antigen-pulsed autologous dendritic cells
- Restoration of tumor specific human leukocyte antigens class I-restricted cytotoxicity by dendritic cell stimulation of tumor infiltrating lymphocytes in patients with advanced ovarian cancer
Showing 5 of 8 shared publications
Horacio Gómez-Acevedo
University of Arkansas for Medical Sciences
8 shared publications
In database
- Neutralization of oxidized phospholipids attenuates age‐associated bone loss in mice
- A Neutralizing Antibody Targeting Oxidized Phospholipids Promotes Bone Anabolism in Chow-Fed Young Adult Mice
- Deletion of the scavenger receptor Scarb1 in osteoblast progenitors does not affect bone mass
- RETRACTED: Deletion of the scavenger receptor Scarb1 in myeloid cells does not affect bone mass
- Deletion of the Scavenger Receptor Scarb1 in Myeloid Cells Does Not Affect Bone Mass
Showing 5 of 8 shared publications
Ha‐Neui Kim
University of Arkansas for Medical Sciences
7 shared publications
In database
- A Neutralizing Antibody Targeting Oxidized Phospholipids Promotes Bone Anabolism in Chow-Fed Young Adult Mice
- RETRACTED: Deletion of the scavenger receptor Scarb1 in myeloid cells does not affect bone mass
- Deletion of the Scavenger Receptor Scarb1 in Myeloid Cells Does Not Affect Bone Mass
- Retraction notice to “Deletion of the scavenger receptor Scarb1 in myeloid cells does not affect bone mass” [Bone 170(2023) 116702]
- OR27-02 The Bone Anabolic Effect Of An Antibody Blocking Oxidized Phospholipids Is Associated With An Increase In Wnt10b In Osteoblasts.
Showing 5 of 7 shared publications
Stavros C. Manolagas
University of Arkansas for Medical Sciences
7 shared publications
In database
- Neutralization of oxidized phospholipids attenuates age‐associated bone loss in mice
- A Neutralizing Antibody Targeting Oxidized Phospholipids Promotes Bone Anabolism in Chow-Fed Young Adult Mice
- Deletion of the scavenger receptor Scarb1 in osteoblast progenitors does not affect bone mass
- RETRACTED: Deletion of the scavenger receptor Scarb1 in myeloid cells does not affect bone mass
- Deletion of the Scavenger Receptor Scarb1 in Myeloid Cells Does Not Affect Bone Mass
Showing 5 of 7 shared publications
Teenamol E. Joseph
Central Arkansas Veterans Healthcare System
7 shared publications
In database
- Neutralization of oxidized phospholipids attenuates age‐associated bone loss in mice
- Deletion of the scavenger receptor Scarb1 in osteoblast progenitors does not affect bone mass
- RETRACTED: Deletion of the scavenger receptor Scarb1 in myeloid cells does not affect bone mass
- Deletion of the Scavenger Receptor Scarb1 in Myeloid Cells Does Not Affect Bone Mass
- Retraction notice to “Deletion of the scavenger receptor Scarb1 in myeloid cells does not affect bone mass” [Bone 170(2023) 116702]
Showing 5 of 7 shared publications
Intawat Nookaew
Winthrop Rockefeller Foundation
6 shared publications
In database
- Reduced osteoprotegerin expression by osteocytes may contribute to rebound resorption after denosumab discontinuation
- Neutralization of oxidized phospholipids attenuates age‐associated bone loss in mice
- A NOTCH3-CXCL12-driven myeloma-tumor niche signaling axis promotes chemoresistance in multiple myeloma
- Single-cell Transcriptome Analysis Identifies Senescent Osteocytes as Contributors to Bone Destruction in Breast Cancer Metastasis
- OR27-02 The Bone Anabolic Effect Of An Antibody Blocking Oxidized Phospholipids Is Associated With An Increase In Wnt10b In Osteoblasts.
Showing 5 of 6 shared publications
Similar Researchers
Based on overlapping research topics
Olivia Reyes‐Castro
University of Arkansas for Medical Sciences
Bone Metabolism and Diseases
Cancer Cells and Metastasis
Disease Mechanisms Research
Noemi Garcia Garcia
University of Arkansas for Medical Sciences
Cancer Cells and Metastasis
Disease Mechanisms Research
Cancer Treatment and Pharmacology
Anna Radomińska‐Pandya
University of Arkansas for Medical Sciences
Cancer Cells and Metastasis
Metabolism and Genetic Disorders
Cancer Treatment and Pharmacology
Teresita Bellido
University of Arkansas for Medical Sciences
Bone Metabolism and Diseases
Disease Mechanisms Research
Metabolism and Genetic Disorders
Sudipta Baroi
University of Arkansas for Medical Sciences
Bone Metabolism and Diseases
Disease Mechanisms Research
Metabolism and Genetic Disorders
Jesús Delgado‐Calle
University of Arkansas for Medical Sciences
Bone Metabolism and Diseases
Cancer Cells and Metastasis
Disease Mechanisms Research